Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation

By Gouin-Thibault I.   Arkam R.   Nassiri S.   de la Tourette A.   Conard J.   Horellou M.H.   Elalamy I.   Samama M.M.  

Thrombosis Research, Vol. 107, Iss. 1, 2002-07 ,pp. : 7-11

Elsevier

Access to resources Recommend Favorite

Lupus anticoagulant, Factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis

By Uthman Imad   Khalil Ismail   Sawaya Raja   Taher Ali  

Clinical Rheumatology, Vol. 23, Iss. 4, 2004-08 ,pp. : 362-363

Springer Publishing Company

Access to resources Recommend Favorite

PULMONARY EMBOLISM AND PREMATURE LABOR IN A PATIENT WITH BOTH FACTOR V LEIDEN MUTATION AND METHYLENETETRAHYDROFOLATE REDUCTASE GENE C677T MUTATION

By Peng F.   Triplett D.   Barna L.   Morrical D.  

Thrombosis Research, Vol. 83, Iss. 3, 1996-08 ,pp. : 243-251

Elsevier

Access to resources Recommend Favorite

Evaluation of Role of Factor V Leiden Mutation in Fatal Pulmonary Thromboembolism - prevalence of factor V Leiden

By Dunn S.T.   Trong S.  

Thrombosis Research, Vol. 91, Iss. 1, 1998-07 ,pp. : 7-14

Elsevier

Access to resources Recommend Favorite

Hyperhomocysteinemia and Other Newly Recognized Inherited Coagulation Disorders (Factor V Leiden and Prothrombin Gene Mutation) in Patients with Idiopathic Cerebral Vein Thrombosis

By  

Cerebrovascular Diseases, Vol. 17, Iss. 2-3, 2003-12 ,pp. : 153-159

Karger

Access to resources Recommend Favorite